𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Identification and characterization of a HER-2/neuepitope as a potential target for cancer immunotherapy

✍ Scribed by Eftychia Lekka; Angelos D. Gritzapis; Sonia A. Perez; Nikolaos Tsavaris; Ioannis Missitzis; Avgi Mamalaki; Michael Papamichail; Constantin N. Baxevanis

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
534 KB
Volume
59
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The forkhead box M1 transcription factor
The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapy
✍ Kazunori Yokomine; Satoru Senju; Tetsuya Nakatsura; Atsushi Irie; Yuki Hayashida πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 509 KB

## Abstract The present study attempted to identify a target antigen for immunotherapy for cholangiocarcinoma. Forkhead box M1 (FOXM1) was selected as a candidate antigen based on the data of previous cDNA microarray analysis of clinical samples of cholangiocarcinoma. The level of __FOXM1__ mRNA wa

Disialoganglioside GD2 and a novel tumor
Disialoganglioside GD2 and a novel tumor antigen: Potential targets for immunotherapy of desmoplastic small round cell tumor
✍ Modak, Shakeel ;Gerald, William ;Cheung, Nai-Kong V. πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 192 KB

## Abstract ## Background Desmoplastic small round cell tumor (DSRCT) is an aggressive and often misdiagnosed neoplasm of children and young adults. It is chemotherapy‐sensitive, yet patients often relapse off therapy because of residual microscopic disease at distant sites: peritoneum, liver, lym

Characterization of a spontaneously aris
Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy
✍ Dianne Khurana; Elizabeth A. Martin; Jan L. Kasperbauer; Bert W. O'Malley Jr; Di πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 237 KB πŸ‘ 1 views

## Abstract ## Background To develop novel therapeutic approaches for patients with head and neck malignancies, poorly immunogenic murine models of squamous cell carcinoma (SCC) need to be defined. ## Methods The phenotype, growth characteristics, and responsiveness to tumor‐specific T‐cell tran